New test may predict immunotherapy success in bladder cancer

NCT ID NCT06738797

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new lab test called SPHERTEST to see if it can predict how well bladder cancer patients will respond to immunotherapy. Researchers will take blood and tumor samples from 32 patients with advanced bladder cancer to see if the test's prediction matches real treatment outcomes. The goal is to find a way to personalize treatment and avoid giving ineffective therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROGENITAL NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Urogenital Neoplasms urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Nimes

    RECRUITING

    Nîmes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Antoine Lacassagne

    NOT_YET_RECRUITING

    Nice, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Régional du Cancer de Montpellier

    NOT_YET_RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut du Cancer de Montpellier

    NOT_YET_RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Iuct Oncopole

    RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••